PHI with Abduction restriction
How does this condition affect your private health insurance?
Abspreizhemmung, or abduction inhibition, describes a restricted ability to move a joint, most notably the hip, away from the body's midline. In infants, it's a crucial clinical sign of developmental dysplasia of the hip (DDH), a condition where the hip joint has not formed properly, often leading to instability or dislocation. This restriction indicates the femoral head isn't correctly seated in the acetabulum, limiting outward thigh movement. Untreated, DDH can cause chronic pain, gait abnormalities, leg length discrepancy, and early-onset osteoarthritis. Early detection via examination and ultrasound is vital for successful conservative treatment, often with special braces or harnesses, aiming for complete anatomical correction and normal hip function.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 10%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to several months (e.g., 6-12 weeks for harness treatment)
Duration of Illness (Lifetime)
One-time event if successfully treated in infancy; chronic if untreated leading to lifelong orthopedic issues
Cost of Treatment (Initial)
Moderate (e.g., $500-$2,000 for conservative treatment); higher if surgery is needed ($10,000-$30,000+)
Cost of Treatment (Lifetime)
Low if completely resolved after early treatment; very high if complications arise or if untreated, potentially requiring multiple surgeries and long-term care
Mortality Rate
Negligible
Risk of Secondary Damages
High (e.g., 80-90%) if untreated or treatment is delayed, leading to osteoarthritis and chronic pain; very low with early successful treatment
Probability of Full Recovery
Very high (e.g., >95%) with early diagnosis and appropriate conservative treatment; significantly lower if diagnosis or treatment is delayed
Underlying Disease Risk
Low for systemic diseases; occasionally associated with other musculoskeletal issues like torticollis or metatarsus adductus (e.g., 10-20%)